Inovio Forced To Delay Planned Testing Of Covid-19 Vaccine; Stock Plummets

Inovio Forced To Delay Planned Testing Of Covid-19 Vaccine; Stock Plummets

Inovio Pharmaceuticals early Monday said the FDA had forced it to delay the start of final-phase testing on its Covid-19 vaccine until some questions could be answered; INO stock crashed.